TipRanks
Go Ultimate55% OFF

AEON Biopharma (AEON) Stock Forecast & Price Target

242 Followers
See the Price Targets and Ratings of:

AEON Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to AEON Biopharma in the past 3 months

AEON Stock 12 Month Forecast

$1.67▲(686.16% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for AEON Biopharma in the last 3 months. The average price target is $1.67 with a high forecast of $2.00 and a low forecast of $1.20. The average price target represents a 686.16% change from the last price of $0.21.
Highest Price Target$2.00Average Price Target$1.67Lowest Price Target$1.20

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for AEON
Price TargetFollowArticle
Lake Street$1→$2buy843.40%UpsideReiterated10/01/26
Laidlaw$1.80buy749.06%UpsideInitiated09/09/26
H.C. Wainwright$5→$1.20buy466.04%UpsideReiterated08/14/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRVITrevi Therapeutics
EHCEncompass Health
MDWDMediwound
OVIDOvid Therapeutics
ONCBeOne Medicines

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering AEON Biopharma

3 Months
Douglas Tsao
Douglas TsaoH.C. Wainwright
Success Rate3/8 ratings generated profit
38%
Average Return
-20.57%

Copying Douglas Tsao's trades and holding each position for 3 Months would result in 37.50% of your transactions generating a profit, with an average return of -20.57% per trade.

1 Year
Douglas Tsao
Douglas TsaoH.C. Wainwright
Success Rate0/8 ratings generated profit
0%
Average Return
-84.49%

Copying Douglas Tsao's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -84.49% per trade.

2 Years
Douglas Tsao
Douglas TsaoH.C. Wainwright
Success Rate0/8 ratings generated profit
0%
Average Return
-89.96%

Copying Douglas Tsao's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -89.96% per trade.

AEON Analyst Recommendation Trends

01234Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for AEON
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy13442
Buy00000
Hold00000
Sell00000
Strong Sell00000
total13442

In the current month, AEON has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AEON average Analyst price target in the past 3 months is 1.67.

AEON Financial Forecast

$-7$-5.25$-3.5$-1.75$0Q4 2025Q2 2026Q3 2026
High$-0.03
Consensus$-0.08
Low$-0.13

AEON Earnings Forecast

Next quarter’s earnings estimate for AEON is -$0.08 with a range of -$0.13 to -$0.03. The previous quarter’s EPS was -$0.02. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q4 2025Q2 2026Q3 2026
High$0.00
Consensus$0.00
Low$0.00

AEON Sales Forecast

Next quarter’s sales forecast for AEON is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

AEON Stock Forecast FAQ

What is AEON’s average 12-month price target, according to analysts?
Based on analyst ratings, AEON Biopharma’s 12-month average price target is $1.67.
What is AEON’s upside potential, based on the analysts’ average price target?
AEON Biopharma has 686.16% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AEON a Buy, Sell or Hold?
AEON Biopharma has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is AEON Biopharma’s price target?
The average price target for AEON Biopharma is $1.67. This is based on 3 12-month price targets, issued in the past 3 months. The highest analyst price target is $2.00, the lowest forecast is $1.20. The average price target represents a 686.16% increase from the current price of $0.212.
What do analysts say about AEON Biopharma?
AEON Biopharma’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of AEON?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.